IDE Group
Ryland Jin is a finance professional with extensive experience in managerial roles within the finance sector. Currently serving as Finance Manager at IDE Group since July 2021, Ryland has previously held similar positions at Perrigo Australia from November 2015 to November 2016 and at Omega Pharma from February 2007 to November 2015. Prior to these management roles, Ryland worked as a Financial Accountant and Accountant at Omega Pharma and Broadway Group, respectively. Educational qualifications include a Master of Professional Accounting with average distinction from the University of Wollongong (2003-2005) and a Bachelor of Economics in Trade and Economics from Tianjin University of Commerce, China (1998-2002).
This person is not in any teams
IDE Group
Building together to create. In a world full of ideas, we navigate through uncertainty to identify and help solve complex problems. Our teams challenge and reframe the status quo to identify new and better ways of doing things. Simultaneously, we integrate technology, business and design to create and grow disruptive businesses. We are experts at taking and managing risks to maximise the chance of strong commercial success. This is critical to our and our partners' success in building better futures. Better futures for health start here. IDE's integrated cross-functional teams have grown over 100 medtech companies and realised over 500 projects through our comprehensive set of commercialisation services; Funding & Investing, Strategy & Research, Product Development and Legal Manufacturing & Distribution Services. We work with companies and world-leading businesses across our offices and manufacturing presences in Philadelphia, Rotterdam, Shenzhen, Ningbo and Sydney.